News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Conference News THT 2025 AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF Todd Neale February 13, 2025
News Conference News ISC 2025 Lower Diagnostic Success With Transradial Cerebral Angiography Todd Neale February 07, 2025
News Conference News ISC 2025 Stroke Thrombectomy Doesn’t Help for Blockages in Smaller Vessels Todd Neale February 06, 2025
News Conference News STS 2025 Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’ Yael L. Maxwell February 05, 2025
News Conference News STS 2025 Second Annual STS Compensation Survey Finds Gaps Persist By Gender Yael L. Maxwell January 28, 2025
News Conference News STS 2025 Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival Yael L. Maxwell January 27, 2025
News Conference News PCR London Valves 2024 Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP Michael O'Riordan December 05, 2024
News Conference News PCR London Valves 2024 Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE Michael O'Riordan December 03, 2024
News Conference News PCR London Valves 2024 Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI Michael O'Riordan December 02, 2024
News Conference News PCR London Valves 2024 Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years Michael O'Riordan November 27, 2024
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News AHA 2024 ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS Michael O'Riordan November 21, 2024
News Conference News AHA 2024 Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360 Michael O'Riordan November 18, 2024
News Conference News AHA 2024 GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes Michael O'Riordan November 17, 2024
News Conference News AHA 2024 Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F Michael O'Riordan November 16, 2024
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Conference News AHA 2024 US Obesity Epidemic Continues to Skyrocket, With No End in Sight Michael O'Riordan November 15, 2024